Skip to main content
. 2015 Sep 16;6(32):33675–33688. doi: 10.18632/oncotarget.5284

Figure 7. HO-1 expression correlates with E-cadherin levels in prostate cancer (PCa) and metastatic cancers.

Figure 7

A–D. Expressions of HO-1 and E-cadherin were evaluated in consecutive sections of 35 prostate cancer and corresponding BPH samples. Cytoplasmic, nuclear and stromal HO-1 were evaluated and correlated with E-cadherin expression in the samples. Note: Cytoplasmic but not nuclear or stromal HO-1 correlates with E-cadherin expression.